Close
Smartlab Europe
Achema middle east

Press Releases

Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA

Johnson & Johnson announced the U.S. FDA has issued Emergency Use Authorization (EUA) for a booster dose of the Johnson & Johnson COVID-19 vaccine for adults aged 18 and older at least two months following primary vaccination with single-shot...

A collaboration to enhance the delivery of biotherapeutics and generate transformative therapies for patients

Crystec Ltd. and Biosidus S.A. are delighted to announce their collaboration focused on enhancing the delivery and performance of biotherapeutics. The overarching aim of the non-exclusive partnership is to apply Crystec’s proprietary mSAS® (modified supercritical antisolvent) supercritical fluid particle...

Turkish Cargo Has Been Carrying Cancer Medicine for 25 Years

Possessing the world’s strongest cargo flight network, Turkish Cargo contributes its strength to Turkey’s medical exports. Flag carrier air cargo brand has been carrying Turkey’s medicine and medical products to over 50 countries in five continents for over 25...

Healthtech company InSilicoTrials releases two new, state-of-the-art simulation tools for oncology

InSilicoTrials has been innovating the healthcare sector for some years now, helping pharmaceutical companies reduce the time and cost of drug development using modeling & simulation. The release of two new products for oncology that have no equals on...

Symbiosis Pharmaceutical Services Starts Producing Sevuparin for Modus Future Clinical Development in Sepsis/septic shock

Modus Therapeutics Holding AB , a company developing innovative treatments for patients with high unmet medical needs, announces that Symbiosis Pharmaceutical Services Ltd (“Symbiosis”), a specialist contract manufacturing organization (CMO), has started manufacturing sevuparin drug product securing the supply...

BeiGene Announces BRUKINSA Approved for Treatment of Patients with Mantle Cell Lymphoma

BeiGene, a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide,  announced that BRUKINSA® (zanubrutinib) has been approved in Australia for the treatment of adult patients with mantle...

Etihad Cargo Expands its African Footprint with the Signing of Pharma Agreement with Astral Aviation and Kenya Airways

Etihad Cargo, the cargo and logistics arm of Abu Dhabi’s Etihad Aviation Group, has expanded its pharma sector reach into Africa with the signing of a Service Legal Agreement (SLA) with Astral Aviation and Kenya Airways to provide reliable...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »